| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2016 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 19 | Q2 2024 | 90.1% |
| Vericel Corporation | 19 | Q2 2024 | 14.5% |
| Five9, Inc. | 19 | Q2 2024 | 11.2% |
| ISHARES TR | 16 | Q2 2024 | 16.7% |
| ISHARES TR | 16 | Q2 2024 | 10.6% |
| ISHARES TR | 16 | Q2 2024 | 0.1% |
| ISHARES TR | 16 | Q2 2024 | 0.1% |
| ISHARES TR | 16 | Q2 2024 | 0.0% |
| ISHARES TR | 16 | Q2 2024 | 0.0% |
| ISHARES TR | 16 | Q2 2024 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-07-29 |
| 13F-HR | 2024-06-17 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.